Correlation Between EnGene Holdings and Beam Therapeutics

Can any of the company-specific risk be diversified away by investing in both EnGene Holdings and Beam Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining EnGene Holdings and Beam Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between enGene Holdings Common and Beam Therapeutics, you can compare the effects of market volatilities on EnGene Holdings and Beam Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in EnGene Holdings with a short position of Beam Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of EnGene Holdings and Beam Therapeutics.

Diversification Opportunities for EnGene Holdings and Beam Therapeutics

-0.24

Correlation Coefficient

EnGene Holdings  Beam Therapeutics

Very good diversification

The 3 months correlation between EnGene and Beam is -0.24. Overlapping area represents the amount of risk that can be diversified away by holding enGene Holdings Common and Beam Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beam Therapeutics and EnGene Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on enGene Holdings Common are associated (or correlated) with Beam Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beam Therapeutics has no effect on the direction of EnGene Holdings i.e., EnGene Holdings and Beam Therapeutics go up and down completely randomly.

Pair Corralation between EnGene Holdings and Beam Therapeutics

Given the investment horizon of 90 days enGene Holdings Common is expected to under-perform the Beam Therapeutics. In addition to that, EnGene Holdings is 2.94 times more volatile than Beam Therapeutics. It trades about -0.02 of its total potential returns per unit of risk. Beam Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest  2,665  in Beam Therapeutics on September 25, 2024 and sell it today you would earn a total of  216.00  from holding Beam Therapeutics or generate 8.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

enGene Holdings Common  vs.  Beam Therapeutics

enGene Holdings Common

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in enGene Holdings Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, EnGene Holdings displayed solid returns over the last few months and may actually be approaching a breakup point.

Beam Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Beam Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain basic indicators, Beam Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with EnGene Holdings and Beam Therapeutics

The main advantage of trading using opposite EnGene Holdings and Beam Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if EnGene Holdings position performs unexpectedly, Beam Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beam Therapeutics will offset losses from the drop in Beam Therapeutics' long position.

The idea behind enGene Holdings Common and Beam Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.